Abstract
The formation of human enamel is highly regulated at the molecular level and involves thousands of genes. Requisites for development of this highly mineralized tissue include cell differentiation; production of a unique extracellular matrix; processing of the extracellular matrix; altering of cell function during different stages of enamel formation; cell movement and attachment; regulation of ion and protein movement; and regulation of hydration, pH, and other conditions of the microenvironment, to name just a few. Not surprising, there is a plethora of hereditary conditions with an enamel phenotype. The objective of this review was to identify the hereditary conditions listed on Online Mendelian Inheritance in Man (OMIM) that have an associated enamel phenotype and whether a causative gene has been identified. The OMIM database was searched with the terms amelogenesis, enamel, dental, and tooth, and all results were screened by 2 individuals to determine if an enamel phenotype was identified. Gene and gene product function was reviewed on OMIM and from publications identified in PubMed. The search strategy revealed 91 conditions listed in OMIM as having an enamel phenotype, and of those, 71 have a known molecular etiology or linked genetic loci. The purported protein function of those conditions with a known genetic basis included enzymes, regulatory proteins, extracellular matrix proteins, transcription factors, and transmembrane proteins. The most common enamel phenotype was a deficient amount of enamel, or enamel hypoplasia, with hypomineralization defects being reported less frequently. Knowing these molecular defects allows an initial cataloging of molecular pathways that lead to hereditary enamel defects in humans. This knowledge provides insight into the diverse molecular pathways involved in enamel formation and can be useful when searching for the genetic etiology of hereditary conditions that involve enamel.
Keywords: genes, amelogenesis, mutations, protein, matrix, development
Introduction
Enamel is the hardest mammalian tissue and is derived from the ectodermally derived oral epithelium (Simmer and Fincham 1995). The oral epithelium interacts with the ectomesenchyme through a series of signaling events that result in the epithelial cells differentiating to ameloblasts. Ameloblasts generate the enamel tissue that covers the human dental crown and are responsible for establishing the enamel’s unique composition and structure that account for its remarkable wear, fracture resistance, and insulating properties. This process of amelogenesis is accomplished through a temporally restricted and highly regulated series of events that include development of a specific extracellular matrix, matrix processing, and controlling the microenvironment of the developing enamel tissue (Smith 1998; He et al. 2010; Lacruz et al. 2012). These processes are highly regulated at the molecular level, with amelogenesis ultimately involving thousands of genes and their products (Sehic et al. 2010; Lacruz et al. 2011). Not unexpectedly, these processes involve numerous developmental and regulatory pathways that could lead to abnormal enamel development and pathology.
Some of the processes requisite for enamel formation are likely sensitive to perturbations leading to abnormal ameloblast functions. For example, abnormal secretion and processing of the enamel extracellular matrix result from different allelic and nonallelic mutations (Lagerstrom-Fermer et al. 1995; Hu and Yamakoshi 2003; Hart et al. 2004; Gasse et al. 2013). Phenotypes resulting from the altered gene expression and gene products are varied and can affect the amount, structure, and/or composition of enamel (Wright 2006). One would predict that the enamel phenotypes will be determined by the specific genetic mutation, the nature of the mutation and changes in the derived protein, the function of the protein, and the temporal and spatial expression of the protein (Wright et al. 2003). Molecular defects can alter enamel development by directly affecting gene expression of the enamel forming cells (e.g., ameloblasts secrete an abnormal matrix) or secondarily or indirectly where the gene may not be expressed by ameloblasts but the resulting changes influence enamel formation (e.g., systemic changes in pH regulation). Genetic mutations can directly affect the oral epithelium, thereby altering the differentiation or function of the ameloblasts or adjacent supporting cells (e.g., stratum intermedium). For example, junctional epidermolysis bullosa (Online Mendelian Inheritance of Man [OMIM] 226700, 226650) is associated with enamel hypoplasia secondary to abnormal laminin 5 formation that is critical for cell attachment (Wright et al. 1993; Aberdam et al. 1994). There are many syndromes caused by genes that are expressed by the oral epithelium and ameloblasts and that have an associated enamel phenotype. Transient expression of a gene and its altered protein (e.g., dentin sialophosphoprotein expression by preameloblasts) can be associated with abnormal enamel formation (Wang et al. 2011). Genes coding for proteins important for enamel formation have diverse functions. Mutations in these genes produce changes affecting molecular pathways, resulting in a variety of enamel phenotypes, such as a deficiency in amount (hypoplasia), a change in composition (e.g., hypomineralization), or a change in structure.
Genetic alterations also can affect enamel formation through secondary actions or distresses that do not involve ameloblast dysfunction caused by gene expression of the ameloblast. Through a variety of diverse processes, genes that are transiently or not expressed by ameloblasts can result in altered enamel development. Genes expressed by the ectomesenchyme or its derived odontoblast cells appear to be critical for signaling the ameloblasts, and abnormalities in this process could result in aberrant ameloblast function. This may well occur in certain cases of dentinogenesis imperfecta type II (OMIM 125490) caused by DSPP mutations that display enamel defects in addition to the more typical dentin defects. Interrogation of databases of human mutations can provide insights into the molecular etiologies associated with developmental defects of human teeth. The database OMIM provides a valuable resource of regularly updated genetic and phenotype information on hereditary human conditions. The OMIM database is updated regularly and is organized to help delineate the mode of inheritance and to facilitate practitioners searching for current information on hereditary conditions. The database includes hereditary conditions with known phenotypes and includes information related to genes that are not currently associated with a phenotype (e.g., tuftelin, ameloblastin). The purpose of this investigation was to explore our current understanding of the molecular mechanisms and the developmental pathways involved in the formation of enamel defects in humans. This knowledge will not only help explain how certain enamel phenotypes develop but also provide a framework for grouping or classifying these conditions based on the molecular defect and the resulting functional change.
Methods
The OMIM database (http://www.ncbi.nlm.nih.gov/omim/) was interrogated for genes or known hereditary conditions listing any phenotype with an enamel component. The database was searched with the terms amelogenesis, enamel, dental, and tooth. All results were screened by 2 individuals to determine if an enamel phenotype was identified. Positive hits were interrogated regarding the nature and phenotype of the enamel defect by review of articles cited in OMIM. The primary outcome measured was enamel phenotype. Genes associated with enamel formation but not associated with an enamel phenotype were not included. The purported function of each gene and its protein were searched in OMIM. Additional articles from PubMed were pulled to help ascertain the function of the different genes and their products associated with known enamel malformations. The search was completed August 30, 2014.
Results
Interrogation of the OMIM database revealed responses when it was searched via tooth (n = 958), dental (n = 677), enamel (n = 162), and amelogenesis (n = 47). Further interrogation of these citations revealed 91 conditions listed in OMIM that had an enamel phenotype. The most common enamel phenotype was a deficient amount of enamel or enamel hypoplasia with hypomineralization defects being less commonly reported. Dysplastic enamel was described for many cases, but it was not defined regarding the exact nature of the defect. The data presented in the tables represent the enamel phenotype descriptions provided in OMIM. While the different designations of enamel defects can be confusing (e.g., dysplastic, hypomineralized, hypocalcified, hypomaturation), we did not attempt to presume that we could cluster these disparate phenotypes even when we referred to the original publications to help clarify the phenotype. Of the 91 conditions with a described enamel phenotype, 71 had a known molecular etiology or linked genetic loci listed in the OMIM database (Table 1). The molecular basis of 23% of the hereditary enamel defects was unknown or not listed on OMIM. The purported protein function of those conditions with a known genetic basis included enzymes, regulatory proteins, extracellular matrix proteins, transcription factors, transmembrane proteins, and a variety of other proteins with diverse functions (Fig.). Functionality of the protein products of genes associated with each hereditary enamel defect identified on OMIM was further interrogated (OMIM, PubMed search) regarding its putative role in enamel formation (Table 2). Despite extensive research, the role of these diverse gene products in enamel formation remain, for the most part, poorly understood.
Table 1.
Hereditary Conditions with Enamel Defects: OMIM Designations and Genes.
| OMIM | Category of Condition and Inheritance | Gene/Locus | Enamel Phenotype | Protein Function |
|---|---|---|---|---|
| Nonsyndromic enamel conditions | ||||
| Autosomal dominant | ||||
| 104500 | Amelogenesis imperfecta, type IB; AI1B | ENAM | Localized hypoplastic, generalized hypoplastic | ECM secreted by ameloblasts |
| 104510 | Amelogenesis imperfecta, type IV; AI4 | DLX3 | TDO | Transcription factor |
| 104530 | Amelogenesis imperfecta, hypoplastic type | nk | Hypoplastic—failure to erupt and calcification of pulp | nk |
| 130900 | Amelogenesis imperfecta, type III; AI3 | FAM83H | Localized or generalized hypomineralized enamel | nk |
| Autosomal recessive | ||||
| 204650 | Amelogenesis imperfecta, type IC; AI1C | ENAM | Generalized hypoplastic | ECM secreted by ameloblasts |
| 204700 | Amelogenesis imperfecta, hypomaturation type, IIA1; AI2A1 | KLK4 | Normal enamel thickness—hypomineralized orange brown color | Maturation stage enamel proteinase |
| 612529 | Amelogenesis imperfecta, hypomaturation type, IIA2; AI2A2 | MMP20 | Normal enamel thickness—hypomineralized orange brown color | Secretory stage enamel proteinase |
| 613211 | Amelogenesis imperfecta, hypomaturation type, IIA3; AI2A3 | WDR72 | Hypomaturation creamier, opaque enamel upon eruption. discoloration and loss of tissue posteruption | nk |
| 614253 | Amelogenesis imperfecta and gingival fibromatosis syndrome | FAM20A | Generalized hypoplastic and failure of tooth eruption, gingival hypertrophy | nk |
| 614832 | Amelogenesis imperfecta, hypomaturation type, IIA4; AI2A4 | C4ORF26 | Hypomaturation AI | May encode an extracellular matrix acidic phosphoprotein |
| 615887 | Amelogenesis imperfecta hypomaturation type 1A5 | SLC24A4 | Hypomaturation AI | Na/K exchanger |
| X-linked | ||||
| 301200 | Amelogenesis imperfecta, type IE; AI1E | AMELX | Hypoplasia, hypomaturation depending on mutation and protein effect | ECM secreted by ameloblasts |
| 301201 | Amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 2 | Xq22-q28 | Enamel hypoplasia and hypomaturation | nk |
| Syndrome-associated enamel defects | ||||
| Autosomal dominant | ||||
| 103580 | Pseudohypoparathyroidism, type IA; PHP1A | GNAS | Enamel hypoplasia | Transcription factor |
| 104570 | Ameloonychohypohidrotic syndrome | nk | Enamel hypoplasia, hypomineralization | nk |
| 119600 | Cleidocranial dysplasia | RUNX2 | Enamel hypoplasia, failure of exfoliation of the primary dentition | Nuclear protein transcription factors |
| 125500 | Dentinogenesis imperfecta, shields type III | DSPP | Enamel hypoplasia, aplasia and pitting | Two proteins associated with biomineralization of teeth |
| 129540 | Ectodermal dysplasia syndrome with distinctive facial appearance and preaxial polydactyly of feet | nk | Thin dental enamel | nk |
| 133705 | External auditory canal, bilateral atresia of, with congenital vertical talus | nk | Dysplastic enamel | nk |
| 146300 | Hypophosphatasia, adult | ALPL | Enamel hypoplasia | Membrane bound glycosylated enzyme |
| 149730 | Lacrimoauriculodentodigital syndrome | FGFR2; FGFR3, FGFR10 | Enamel dysplasia, peg shaped lateral incisors | Polypeptide growth factors involved in mitogenesis, angiogenesis, and wound healing |
| 151050 | Lenz-majewski hyperostotic dwarfism | PTDSS1 | Enamel dysplasia | nk |
| 162200 | Neurofibromatosis, type I; NF1 | NF1 | Enamel hypoplasia | Cytoplasmic protein, negative regulator |
| 164200 | Oculodentodigital dysplasia | GJA1, connexin-43 gene | Enamel hypoplasia | Component of gap junctions |
| 166750 | Otodental dysplasia | FGF3 | Enamel defects, enlarged canines and molars | Growth factor associated with mitogenic and cell survival activities |
| 173650 | Kindler syndrome | KIND1 | Enamel hypoplasia, dental caries | Structural protein |
| 180500 | Axenfeld-rieger syndrome, type 1; RIEG1 | PITX2; FOXC1 | Enamel hypoplasia, conical and misshapen teeth, hypodontia, and impactions | Bicoid class of homeodomain transcription factors |
| 180849 | Rubinstein-taybi syndrome | CREBBP; EP300 | Enamel hypoplasia, discoloration and wear | Transcriptional coactivation of many different transcription factors |
| 180849 | Rubinstein-taybi syndrome 1 | CREBBP | Enamel hypoplasia, discoloration, hypodontia, talon cusps, screwdriver permanent incisors, enamel wear | Transcriptional coactivator CREB-binding protein |
| 182290 | Smith-magenis syndrome | 3.7-Mb deletion 17p11.2; RAI1 | Enamel hypoplasia, hypomineralized enamel | Regulatory proteins (enhancer) |
| 190320 | Trichodentoosseous syndrome | DLX3 | Enamel hypoplasia, taurodontism | Transcription factor |
| 191100 | Tuberous sclerosis 1 | TSC1 | Pitted hypoplastic enamel | Forms a protein complex that inhibits signal transduction |
| 604292 | Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 | TP63 | Enamel hypoplasia and hypodontia | Transcription factors |
| 612463 | Pseudopseudo-hypoparathyroidism | GNAS | Enamel hypoplasia | Regulatory proteins |
| 612843 | Keratosis follicularis spinulosa decalvans | nk | Enamel hypoplasia | nk |
| 614564 | Cutaneous telangiectasia and cancer syndrome, familial | ATR | Thin discolored enamel and dental caries | Regulator of genomic integrity; kinase enzyme |
| Autosomal recessive | ||||
| 202900 | Alaninuria with microcephaly, dwarfism, enamel hypoplasia, and diabetes mellitus | nk | Enamel hypoplasia | nk |
| 203550 | Alopecia-contractures-dwarfism mental retardation syndrome | nk | Enamel dysplasia and caries | nk |
| 204690 | Enamel-renal syndrome | FAM20A | Enamel hypoplasia, anodontia of permanent teeth | nk |
| 207780 | Aredyld | nk | nk | |
| 210600 | Seckel syndrome 1 | ATR | Enamel hypoplasia | Kinase enzyme |
| 211900 | Tumoral calcinosis, hyperphosphatemic, familial | GALNT3;FGF23; KL | Hypoplastic teeth with fully developed enamel | Catalytic enzyme; Growth factor; type-I membrane protein |
| 212750 | Celiac disease | CELIAC1 | Enamel hypoplasia | Extracellular proteins |
| 216400 | Cockayne syndrome, type A; CSA | ERCC8 | Enamel hypoplasia, dental caries | Regulatory proteins |
| 217080 | Jalili syndrome | CNNM4 | Cone-rod dystrophy and amelogenesis imperfecta | Role in metal ion transport |
| 224300 | Dysosteosclerosis | nk | Hypomineralized enamel (chalky), delayed eruption of primary teeth | nk |
| 225410 | Ehlers-danlos syndrome, type VII, autosomal recessive | ADAMTS2 | Excises the N-propeptide of type I and type II procollagens. NPI enzyme is a metalloproteinase | Enzyme that excises the N-propeptide of type I, type II and type V procollagens |
| 225500 | Ellis-van creveld syndrome | EVC1; EVC2 | Enamel hypoplasia, conical shaped teeth, premature eruption of primary teeth | nk |
| 226440 | Epidermolysis bullosa, late-onset localized junctional, with mental retardation | nk | Enamel hypoplasia | nk |
| 226600 | Epidermolysis bullosa dystrophica, autosomal recessive | COL7A1 | Generalized enamel hypoplasia | Collagen beneath stratified squamous epithelia |
| 226650 | Epidermolysis bullosa, junctional, non-herlitz type | COL17A1;LAMA3; LAMB3;LAMC2; ITGB4 | Enamel hypoplasia | Components of hemidesmosomes important for cell attachment |
| 226670 | Epidermolysis bullosa simplex with muscular dystrophy | PLEC1 | Enamel hypoplasia | Intermediate filament-binding protein |
| 226700 | Epidermolysis bullosa, junctional, herlitz type | LAMA3; LAMB3; LAMC3 | Enamel hypoplasia | Cell adhesion, signal transduction and differentiation of keratinocytes |
| 226730 | Epidermolysis bullosa junctionalis with pyloric atresia | ITGB4; ITGA6 | Enamel hypoplasia | Transmembrane glycoprotein receptors |
| 226750 | Kohlschutter-tonz syndrome | ROGDI | Hypomineralized enamel | Leucine-zipper protein |
| 233400 | Perrault syndrome | HSD17B4 | Enamel hypomineralization | Multifunctional peroxisomal enzyme |
| 234580 | Hearing loss, sensorineural, with enamel hypoplasia and nail defects | nk | Hypomineralized enamel | nk |
| 240300 | Autoimmune polyendocrine syndrome, type I; APS1 | AIRE | Enamel hypoplasia | Autoimmune regulator gene and transcriptional activator |
| 241510 | Hypophosphatasia, childhood | ALPL | Enamel hypoplasia, odontohypophosphatasia | Membrane bound glycosylated enzyme |
| 244460 | Kenny-caffey syndrome, type 1; KCS1 | TBCE | Enamel hypoplasia | Hypocalcemia, seizures, protein folding cofactor |
| 245660 | Laryngoonychocutaneous syndrome | LAMA3 | Hypoplastic enamel, allelic to herlitz EB | Cell adhesion ligand for integrins |
| 251190 | Microcephalic primordial dwarfism, toriello type | nk | Enamel hypoplasia | nk |
| 253000 | Morquio syndrome a | GALNS | Enamel hypoplasia; pitted and reduced thickness | Lysosomal enzyme involved in the catabolism of keratin and chondroitin sulfate |
| 253010 | Morquio syndrome b | GLB1 | Enamel hypoplasia | Lysosomal enzyme |
| 257850 | Oculodentodigital dysplasia, autosomal recessive | GJA1 | Enamel hypoplasia | codes CONNEXIN 43 a major protein of gap junctions |
| 259775 | Raine syndrome | FAM20C | Enamel dysplasia, small teeth | nk |
| 261560 | Pfeiffer-palm-teller syndrome | nk | Enamel hypoplasia | nk |
| 261900 | Pili torti, early-onset | nk | Enamel hypoplasia | nk |
| 264700 | Vitamin d hydroxylation-deficient rickets, type 1A | CYP27B1 | Enamel discoloration permanent teeth | Catalytic enzyme |
| 601539 | Peroxisome Biogenesis Disorder | PEX1, PEX2, PEX26 | Enamel hypoplasia | ATPase enzymes |
| 270200 | Sjogren-larsson syndrome | ALDH3A2 | Enamel hypoplasia | Catalytic enzyme |
| 275450 | Trichoodontoonychial dysplasia | nk | Enamel hypoplasia, anodontia | nk |
| 277440 | Vitamin d-dependent rickets, type 2A; VDDR2A | VDR | Dental anomalies | Hormone receptor |
| 601216 | Platyspondyly with amelogenesis imperfecta | nk | Enamel hypoplasia and hypodontia, discolored enamel | nk |
| 601701 | Arthrogryposis and ectodermal dysplasia | nk | Enamel abnormalities | nk |
| 604278 | Renal tubular acidosis, proximal, with ocular abnormalities and mental retardation | SLC4A4 | Enamel hypoplasia | Sodium bicarbonate cotransporter, regulator |
| 605472 | Usher syndrome, type IIC; USH2C | GPR98, PDZD7 | Enamel hypoplasia | Transmembrane receptor |
| 607626 | Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis | CLDN1 | Enamel dysplasia | Claudin-1 is a tight-junction protein |
| 610319 | Rhizomelic dysplasia, scoliosis, and retinitis pigmentosa | nk | Amelogenesis imperfecta mentioned, hypomaturation | nk |
| 611174 | Hypertelorism, severe, with midface prominence, myopia, mental retardation, and bone fragility | IRX5 | Enamel hypoplasia | Gene regulation; involved in several embryonic developmental processes |
| 612783 | Immune dysfunction with t-cell inactivation due to calcium entry defect 2 | STIM1 | Enamel defect | Calcium sensor that conveys the calcium load of the endoplasmic reticulum |
| X-linked | nk | |||
| 302350 | Nance-horan syndrome | NHS | Enamel hypoplasia, supernumerary teeth and screwdriver incisors | Vasopressin receptor |
| 304800 | Diabetes insipidus, nephrogenic, x-linked | AVPR2 | Hypomineralized enamel | Endoplasmic reticulum transmembrane protein |
| 305600 | Focal dermal hypoplasia | PORCN | Enamel hypoplasia | transmembrane endopeptidase |
| 307800 | Hypophosphatemic rickets, x-linked dominant | PHEX | Enamel hypoplasia | Protease functioning in the signal protein activation |
| 308205 | Ichthyosis follicularis, atrichia, and photophobia syndrome | MBTPS2 | Enamel dysplasia | Membrane-embedded zinc metalloprotease that activates signaling proteins |
| 308205 | Ifap syndrome with or without bresheck syndrome | MBTPS2 | Enamel dysplasia | Phosphatase enzyme |
| 309000 | Lowe oculocerebrorenal syndrome | OCRL1 | Enamel hypoplasia | nk |
| 312830 | Scarf syndrome | nk | Enamel hypocalicification, hypoplasia | nk |
| Inheritance not clearly defined and other | ||||
| 600907 | Enamel hypoplasia, cataracts, and aqueductal stenosis | nk | Enamel hypoplasia of the hypomaturation-hypocalcification type | Tumor suppressor by activation of GPTases |
| 603641 | Neuroendocrine carcinoma of salivary glands, sensorineural hearing loss, and enamel hypoplasia | nk | Enamel hypoplasia | Contiguous gene deletion syndrome; regulatory protein (inhibitor) |
| 613254 | Tuberous sclerosis 2 | TSC2 | Enamel hypoplasia | ECM secreted by ameloblasts |
| 613675 | Chromosome 17q11.2 deletion syndrome, 1.4-MB | 17q11.2; NF1 | Enamel hypoplasia | Transcription factor |
nk indicates that the gene or chromosomal locus for this condition has not been identified and is not known.
OMIM, Online Mendelian Inheritance of Man.
Figure.

The putative protein function of gene products affecting enamel indicated that extracellular matrix proteins and enzymes accounted for about 30% of conditions, about 20% were regulatory proteins or transcription factors, and about 14% were transmembrane or other proteins.
Table 2.
Protein Function during Enamel Formation.
| Protein/Category | Function during Amelogenesis | Phenotype |
|---|---|---|
| Enzyme | ||
| KLK4 | Maturation stage enamel proteinase | Normal enamel thickness—hypomineralized orange brown color |
| MMP20 | Secretory stage enamel proteinase | Normal enamel thickness—hypomineralized orange brown color |
| GALNT3; FGF23; KL | Unknown | Hypoplastic teeth with fully developed enamel |
| ADAMTS2 | Unknown | Enamel attrition |
| HSD17B4 | Unknown | Amelogenesis imperfecta |
| GALNS | Lysosomal enzyme involved in the catabolism of keratin and chondroitin sulfate | Enamel hypoplasia; pitted and reduced thickness |
| GLB1 | Unknown | Enamel hypoplasia |
| CYP27B1 | Catalytic enzyme forming biologically active vitamin D | Enamel discoloration permanent teeth |
| MBTPS2 | Unknown | Enamel dysplasia |
| OCRL1 | Unknown | Enamel hypoplasia |
| ALPL | Hydrolyze monophosphate esters | Enamel hypoplasia |
| ATR | Unknown | Enamel hypoplasia |
| PEX1, PEX2, PEX26 | Unknown | Enamel hypoplasia |
| ALDH3A2 | Unknown | Enamel hypoplasia |
| MBTPS2 | Unknown | Enamel dysplasia |
| PTDSS1 | Enzyme involved in phosphatidylserine production | |
| Extracellular protein | ||
| LAMA3 | Cell adhesion ligand for integrins | Enamel hypoplasia |
| GJA1, connexin-43 gene | Component of gap junctions | Enamel hypoplasia |
| CELIAC1 | Unknown | Enamel hypoplasia |
| LAMA3; LAMB3; LAMC3 | Cell adhesion, signal transduction and differentiation of keratinocytes | Enamel hypoplasia |
| GJA1 | Codes CONNEXIN 43 a major protein of gap junctions | Enamel hypoplasia |
| ENAM | Important in crystallite growth | Enamel hypoplasia |
| AMELX | Important in crystallite growth | Enamel hypoplasia and hypomaturation |
| C4ORF26 | Support crystallite mineralization | Enamel hypomineralization |
| CNNM4 | Transcellular Mg(2+) transport across epithelia | Enamel hypoplasia and hypomineralization |
| CLDN1 | Claudin-1 is a tight-junction protein | Enamel dysplasia |
| DSPP | Unknown | Enamel hypoplasia |
| Growth factor | ||
| FGFR2; FGFR3, FGFR10 | Polypeptide growth factors involved in a variety of activities, including mitogenesis, angiogenesis, and wound healing | Enamel dysplasia, peg shaped lateral incisors |
| FGF3 | Growth factor associated with mitogenic and cell survival activities | Enlarged canines and molars |
| Regulatory protein | ||
| GNAS | Signaling related to parathyroid hormone activity | Enamel hypoplasia |
| ERCC8 | Unknown | Enamel hypoplasia, dental caries |
| SLC4A4 | Sodium bicarbonate cotransporter, regulator | Enamel hypoplasia |
| IRX5 | Unknown | Enamel hypoplasia |
| CREBBP | Transcriptional coactivator CREB-binding protein present during maturation stage | Enamel hypoplasia, hypodontia |
| 3.7-Mb deletion 17p11.2; RAI1 | Unknown | Enamel hypoplasia |
| Unknown | Enamel hypomineralization | |
| AIRE | Unknown | Enamel hypoplasia |
| TSC2 | Unknown | Enamel hypoplasia |
| NF1 | Unknown | Enamel hypoplasia |
| TSC1 | Unknown | Enamel hypoplasia |
| Structural protein | ||
| KIND1 | Unknown | Enamel hypoplasia, dental caries |
| PLEC1 | Unknown | Enamel hypoplasia |
| Transcription factor | ||
| RUNX2 | Regulates expression of genes important to enamel formation | Enamel hypoplasia |
| PITX2; FOXC1 | Bicoid class of homeodomain transcription factors | Enamel hypoplasia, conical and misshapen teeth, hypodontia |
| TP63 | Regulates expression of genes important to enamel formation | Enamel hypoplasia and hypodontia |
| DLX3 | Regulates expression of genes important to enamel formation | Enamel hypoplasia |
| Transmembrane protein | ||
| COL7A1 | May play role in ameloblast differentiation interactions | Enamel hypoplasia |
| COL17A1; LAMA3; LAMB3; LAMC2 | Components of hemidesmosomes important for cell attachment | Enamel hypoplasia |
| ITGB4; ITGA6 | Cell adhesion and migration | Enamel hypoplasia |
| VDR | Role in regulating vitamin D endocrine system | Enamel hypoplasia |
| GPR98, PDZD7 | Unknown | Enamel hypoplasia |
| STIM1 | Calcium sensor that conveys the calcium load of the endoplasmic reticulum | Enamel hypoplasia |
| PORCN | WNT signaling regulation | Enamel hypoplasia |
| PHEX | Endopeptidase regulating phosphate | Enamel hypoplasia |
| AVPR2 | Fluorosis secondary to excess water consumption | Enamel hypomineralization |
| Other proteins | ||
| TBCE | Unknown | Enamel hypoplasia |
| FAM20C | Kinase that phosphorylates a secretory calcium-binding phosphoprotein | Enamel dysplasia |
| FAM20A | Kinase that phosphorylates proteins important to amelogenesis | Enamel hypoplasia |
| WDR72 | Maturation stage endocytotic trafficking | Enamel hypomineralization |
| PTDSS1 | ||
| EVC1, EVC2 | ||
| NHS | ||
| ROGDI | ||
| SLC24A4 | Na+/K+/Ca2+ transporter | Enamel hypomineralization |
Unknown indicates that the gene and its protein have not been studied as related to potential function during amelogenesis.
There were multiple conditions with the term amelogenesis imperfecta identified in the search. The conditions including the term amelogenesis involved nonsyndromic enamel conditions, traditionally referred to as amelogenesis imperfectas, and syndromic conditions affecting tissues or organs in addition to the enamel phenotype (Table 1). Syndromes with an associated enamel phenotype had a variety of other manifestations involving the brain, eyes, kidney, skin, and other tissues and organs depending on the condition. Delineation of hereditary enamel defects as nonsyndromic and syndromic conditions can be problematic due to overlapping phenotypes and multiple listings for disorders caused by allelic mutations (e.g., DLX3 mutations). Here we present these conditions separately in the tables, as this classification approach is still recognized by most clinicians and this is how the conditions are presented in OMIM.
Discussion
The number and functional diversity of genes associated with hereditary enamel defects and the molecular pathways involved is not surprising given the complexity of enamel development. Despite the diversity of molecular defects, the most common phenotype described in our OMIM query was enamel hypoplasia. The specific enamel phenotype is often not described in any detail in OMIM or in the manuscripts reviewed from PubMed. It is not surprising that alterations in a variety of pathways can lead to a phenotype of enamel hypoplasia given the sensitivity and exquisite regulation of the amelogenesis processes. Future studies directed at detailed phenotype characterization of hereditary enamel defects will provide clues regarding the role of genes, proteins, and pathways involved in enamel formation.
The classification of developmental enamel defects has been reviewed and modified for more than 70 years. A variety of nomenclatures and terminologies are being used (Witkop 1989; Aldred et al. 2003). It is primarily in the past decade that a useful understanding of the molecular mechanisms leading to hereditary enamel defects has emerged with many of the genes responsible for enamel defects now identified. This knowledge provides the foundation for understating the molecular controls and pathways leading to hereditary developmental defects of enamel. As we show, the number of syndromes having associated enamel defects is extensive. Some classifications list hereditary enamel defects as syndromic and nonsyndromic forms of amelogenesis imperfecta to help delineate these 2 groups. Our search identified 10 genes listed in OMIM as being associated with conditions involving primarily the enamel (traditional nonsyndromic amelogenesis imperfecta). These 10 genes allow molecular diagnosis of the majority of amelogenesis imperfecta cases; however, there remain individuals with enamel defects that have as yet to be identified genetic mutations that cause the amelogenesis imperfecta phenotype (Wright et al. 2011). One of the genes listed on OMIM as an amelogenesis imperfecta with gingival fibromatosis (OMIM 614253), FAM20A, is now known to be causative of enamel-renal syndrome (OMIM 204690; Wang et al. 2014). These 2 conditions are listed separately on OMIM but appear to be the same entity. In some conditions, such as Kolschutters-Tonz syndrome (OMIM 226750, gene ROGDI), the enamel phenotype appears quite similar to the hypomineralized forms of amelogenesis imperfecta (Schossig et al. 2012). The pathologic mechanism of this neurologic condition and function of the ROGDI gene product remain unknown, but one could speculate that the causative gene is expressed by ameloblasts and that its protein plays a critical role in enamel biomineralization. While the genes are known for many hereditary enamel defects, the protein function and specific mechanisms involved with these conditions remain poorly understood. Future classification of hereditary enamel defects should include organization around the phenotype, mode of inheritance, molecular defect, and protein function and its role in enamel formation or pathologic mechanism. Such a classification system would provide a robust organizational approach that would offer a logical and informative clustering of the diverse hereditary enamel conditions.
Many genetic alterations affect development of epithelial derivatives and can have associated alterations in dental formation, as the oral epithelium is critical to tooth bud initiation. A classic example is the ectodermal dysplasias that are frequently associated with hypodontia and, in some cases, enamel defects (e.g., ectrodactyly, ectodermal dysplasia, and cleft lip/palate; OMIM 604292). Genes that are critical for early tooth formation events, such as invagination and proliferation of the oral epithelium, can result in hypodontia or missing teeth. Such is indeed the case with x-linked hypohidrotic ectodermal dysplasias (OMIM 305100). Mutations affecting genes involving the WNT pathway can be associated with both hypodontia and enamel hypoplasia characterized by thin or pitted enamel (e.g., focal dermal hypoplasia; OMIM 305600; Wang et al. 2007). Because of these genes’ roles in epithelium development, they are associated with many developmental perturbations of ectodermally derived appendages. Table 1 lists those OMIM conditions and the known genes and their purported protein functions related to epithelial growth and development (e.g., KIND1, PORCN, TP63).
Numerous other critical developmental pathways affect epithelium and are associated with enamel defects. For example, the WNT10A, TP63, PORCN, and DLX3 genes are all associated with syndromes that have abnormal ectodermal appendage development and can have defective enamel formation (Price et al. 1998; Adaimy et al. 2007; Wang et al. 2007; Koster 2010). Given that the genes and gene products can be interactive (PORCN and WNT, TP63 and DLX3), it is not surprising that similar developmental defects and phenotypes might occur. Mutations in the PORCN gene are associated with the focal dermal hypoplasia syndrome (OMIM 305600). Focal dermal hypoplasia syndrome is known to have a marked enamel hypoplasia phenotype, but the OMIM description only notes hypoplastic teeth (Murakami et al. 2011). Genetic mutations affecting epithelial integrity can also be associated with developmental enamel defects (e.g., laminin 5; Aberdam et al. 1994). Maintaining an intact sheath of ameloblasts is essential for controlling the microenvironment critical for enamel biomineralization. The ameloblasts control the enamel matrix microenvironment’s ion content, pH, and water content through the expression of numerous genes. Some of these genes are associated with enamel defects, such as the CFTR gene, which codes for the cystic fibrosis conductance transmembrane regulator (Ferrazzano et al. 2012). Mutations in CFTR cause cystic fibrosis (OMIM 219700), and although enamel defects are reported in about half of affected individuals (Ferrazzano et al. 2012), an enamel phenotype is not described in the OMIM database. Not only is this ion channel critical as a chloride ion channel, but it also plays a role in pH modulation (Arquitt et al. 2002). Humans with SLC4A4 mutations (codes for electrogenic sodium base transporter—an important pH regulator; OMIM 3604278) have abnormal enamel development. Recent animal studies indicate that mutations in this gene are associated with proximal tubular acidosis resulting in a systemic acidosis that secondarily causes the defective enamel formation (Wen et al. 2014). This is another example of a genetic mutation secondarily causing an enamel malformation (e.g., systemic acidosis). Nephrogenic diabetes insipidus (OMIM 304800; gene mutations in AVPR2) is associated with a fluorotic enamel phenotype that occurs secondarily to the inability of the renal collecting duct to respond to antidiuretic hormone and the resulting polyuria and polydipsia (Klein 1975).
The list of genes associated with enamel defects has grown tremendously over the past decade. The molecular pathways involved in the development of enamel defects are diverse, and the functionality of the genes and gene products is heterogeneous. Syndrome-associated enamel defects are caused by many genes that affect other tissues, including eye, kidney, brain, and skin, to name just a few. Identification of the genes associated with developmental defects of enamel has been extremely informative in helping advance our knowledge of the molecular control of enamel formation and how genes and gene products can have diverse functions in different tissues. Review of the OMIM database reveals that the phenotype characterization of enamel defects is incomplete and future studies providing more detailed phenotypic evaluation of enamel malformations are needed. Advancing our understanding of the enamel phenotypes, protein function, and developmental pathways will assist in developing a logical and more useful classification system of hereditary enamel disorders.
Author Contributions
J.T. Wright, I.A. Carrion, contributed to conception, design, and data analysis, drafted and critically revised the manuscript; C. Morris, contributed to conception, design, and data analysis, drafted the manuscript. All authors gave final approval and agree to be accountable for all aspects of the work.
Acknowledgments
The authors thank Cynthia Suggs for her support interrogating the OMIM database.
Footnotes
This study was supported by the National Institute of Dental and Craniofacial Research (grant DE016079).
The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.
References
- Aberdam D, Aguzzi A, Baudoin C, Galliano MF, Ortonne JP, Meneguzzi G. 1994. Developmental expression of nicein adhesion protein (laminin-5) subunits suggests multiple morphogenic roles. Cell Adhes Communic. 2(2):115–129. [DOI] [PubMed] [Google Scholar]
- Adaimy L, Chouery E, Megarbane H, Mroueh S, Delague V, Nicolas E, Belguith H, de Mazancourt P, Megarbane A. 2007. Mutation in WNT10A is associated with an autosomal recessive ectodermal dysplasia: the odonto-onycho-dermal dysplasia. Am J Human Genet. 81(4):821–828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aldred MJ, Savarirayan R, Crawford PJ. 2003. Amelogenesis imperfecta: a classification and catalogue for the 21st century. Oral Dis. 9(1):19–23. [DOI] [PubMed] [Google Scholar]
- Arquitt CK, Boyd C, Wright JT. 2002. Cystic fibrosis transmembrane regulator gene (CFTR) is associated with abnormal enamel formation. J Dent Res. 81(7):492–496. [DOI] [PubMed] [Google Scholar]
- Ferrazzano GF, Sangianantoni G, Cantile T, Amato I, Orlando S, Ingenito A. 2012. Dental enamel defects in Italian children with cystic fibrosis: an observational study. Community Dent Health. 29(1):106–109. [PubMed] [Google Scholar]
- Gasse B, Karayigit E, Mathieu E, Jung S, Garret A, Huckert M, Morkmued S, Schneider C, Vidal L, Hemmerlé J, et al. 2013. Homozygous and compound heterozygous MMP20 mutations in amelogenesis imperfecta. J Dent Res. 92(7):598–603. [DOI] [PubMed] [Google Scholar]
- Hart PS, Hart TC, Michalec MD, Ryu OH, Simmons D, Hong S, Wright JT. 2004. Mutation in kallikrein 4 causes autosomal recessive hypomaturation amelogenesis imperfecta. J Med Genet. 41(7):545–549. [DOI] [PMC free article] [PubMed] [Google Scholar]
- He P, Zhang Y, Kim SO, Radlanski RJ, Butcher K, Schneider RA, DenBesten PK. 2010. Ameloblast differentiation in the human developing tooth: effects of extracellular matrices. Matrix Biol. 29(5):411–419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hu JC, Yamakoshi Y. 2003. Enamelin and autosomal-dominant amelogenesis imperfecta. Crit Rev Oral Biol Med. 14(6):387–398. [DOI] [PubMed] [Google Scholar]
- Klein H. 1975. Dental fluorosis associated with hereditary diabetes insipidus. Oral Surg Oral Med Oral Pathol. 40(6):736–741. [DOI] [PubMed] [Google Scholar]
- Koster MI. 2010. p63 in skin development and ectodermal dysplasias. J Invest Dermatol. 130(10):2352–2358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lacruz RS, Smith CE, Chen YB, Hubbard MJ, Hacia JG, Paine ML. 2011. Gene-expression analysis of early- and late-maturation-stage rat enamel organ. Eur J Oral Sci. 119(Suppl 1):149–157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lacruz RS, Smith CE, Moffatt P, Chang EH, Bromage TG, Bringas P, Jr, Nanci A, Baniwal SK, Zabner J, Welsh MJ, et al. 2012. Requirements for ion and solute transport, and pH regulation during enamel maturation. J Cell Physiol. 227(4):1776–1785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lagerstrom-Fermer M, Nilsson M, Bäckman B, Salido E, Shapiro L, Pettersson U, Landegren U. 1995. Amelogenin signal peptide mutation: correlation between mutations in the amelogenin gene (AMGX) and manifestations of X-linked amelogenesis imperfecta. Genomics. 26(1):159–162. [DOI] [PubMed] [Google Scholar]
- Murakami C, de Oliveira Lira Ortega A, Guimarães AS, Gonçalves-Bittar D, Bönecker M, Ciamponi AL. 2011. Focal dermal hypoplasia: a case report and literature review. Oral Surg Oral Med Ooral Pathol. 112(2):e11–e18. [DOI] [PubMed] [Google Scholar]
- Price JA, Bowden DW, Wright JT, Pettenati MJ, Hart TC. 1998. Identification of a mutation in DLX3 associated with tricho-dento-osseous (TDO) syndrome. Hum Mol Genet. 7(3):563–569. [DOI] [PubMed] [Google Scholar]
- Schossig A, Wolf NI, Fischer C, Fischer M, Stocker G, Pabinger S, Dander A, Steiner B, Tönz O, Kotzot D, et al. 2012. Mutations in ROGDI cause Kohlschutter-Tonz syndrome. Am J Hum Genet. 90(4):701–707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sehic A, Risnes S, Khan QE, Khuu C, Osmundsen H. 2010. Gene expression and dental enamel structure in developing mouse incisor. Eur J Oral Sci. 118(2):118–130. [DOI] [PubMed] [Google Scholar]
- Simmer JP, Fincham AG. 1995. Molecular mechanisms of dental enamel formation. Crit Rev Oral Biol Med. 6(2):84–108. [DOI] [PubMed] [Google Scholar]
- Smith CE. 1998. Cellular and chemical events during enamel maturation. Crit Rev Oral Biol Med. 9(2):128–161. [DOI] [PubMed] [Google Scholar]
- Wang SK, Chan HC, Rajderkar S, Milkovich RN, Uston KA, Kim JW, Simmer JP, Hu JC. 2011. Enamel malformations associated with a defined dentin sialophosphoprotein mutation in two families. Eur J Oral Sci. 119(Suppl 1):158–167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang SK, Reid BM, Dugan SL, Roggenbuck JA, Read L, Aref P, Taheri AP, Yeganeh MZ, Simmer JP, Hu JC. 2014. FAM20A mutations associated with enamel renal syndrome. J Dent Res. 93(1):42–48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang X, Reid Sutton V, Omar Peraza-Llanes J, Yu Z, Rosetta R, Kou YC, Eble TN, Patel A, Thaller C, Fang P, et al. 2007. Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause focal dermal hypoplasia. Nat Genet. 39(7):836–838. [DOI] [PubMed] [Google Scholar]
- Wen X, Kurtz I, Paine ML. 2014. Prevention of the disrupted enamel phenotype in slc4a4-null mice using explant organ culture maintained in a living host kidney capsule. PLoS One. 9(5):e97318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Witkop CJ., Jr. 1989. Amelogenesis imperfecta, dentinogenesis imperfecta and dentin dysplasia revisited, problems in classification. J Oral Pathol. 17(9–10):547–553. [DOI] [PubMed] [Google Scholar]
- Wright JT. 2006. The molecular etiologies and associated phenotypes of amelogenesis imperfecta. Am J Med Genet A. 140(23):2547–2555. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wright JT, Fine JD, Johnson LB. 1993. Developmental defects of enamel in humans with hereditary epidermolysis bullosa. Arch Oral Biol. 38(11):945–955. [DOI] [PubMed] [Google Scholar]
- Wright JT, Hart PS, Aldred MJ, Seow K, Crawford PJ, Hong SP, Gibson CW, Hart TC. 2003. Relationship of phenotype and genotype in X-linked amelogenesis imperfecta. Connect Tissue Res. 44(Suppl 1):72–78. [PubMed] [Google Scholar]
- Wright JT, Torain M, Long K, Seow K, Crawford P, Aldred MJ, Hart PS, Hart TC. 2011. Amelogenesis imperfecta: genotype-phenotype studies in 71 families. Cells Tissues Organs. 194(2–4):279–283. [DOI] [PMC free article] [PubMed] [Google Scholar]
